Fabiola D. M.
- Country
- Italy
- Department
- Department of Neuroscience
Research Overview
- Evaluation of Rotigotine and Rivastigmine Combination Therapy on Cognitive Function in Mild to Moderate Alzheimer's Disease: A Phase III Randomized Controlled Trial
- Efficacy and Safety Evaluation of Clenbuterol Hydrochloride in Spinal and Bulbar Muscular Atrophy: A Placebo-Controlled Clinical Trial
- Randomized Phase II/III Trial Evaluating Acetylcarnitine Hydrochloride on Functional Disability Progression in Amyotrophic Lateral Sclerosis Patients
Data & Insights
Has run more than one trial at 4 of 38 partner sites.
Specializations
Neuromuscular Disorders
The investigator specializes in treating Spinal and Bulbar Muscular Atrophy (SBMA), a rare genetic neuromuscular condition that primarily affects motor neurons. Their research explores therapeutic interventions targeting muscle strength and motor function improvement.
- Motor neuron disease management
- Genetic neuromuscular disorders
- Muscle strength preservation
Neurodegenerative Diseases
Focusing on Alzheimer's disease treatment, particularly in its mild to moderate stages. The investigator studies combination therapies targeting cognitive function enhancement, with special attention to frontal lobe functionality.
- Cognitive function preservation
- Memory enhancement therapies
- Combined treatment approaches
Motor Neuron Disease
The investigator conducts research in Amyotrophic Lateral Sclerosis (ALS), examining therapeutic approaches to slow disease progression and maintain functional capabilities. Their work focuses on innovative treatments to preserve patient self-sufficiency.
- Disease progression management
- Functional disability assessment
- Quality of life improvement
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.